Article

Progress in Search for Treatment for Acetaminophen Poisoning

Author(s):

Whether accidental or on purpose, acetaminophen overdose is a common finding in liver poisoning. Researchers at the 2015 Liver Meeting said they have zeroed in on the mechanism at work.

Acetaminophen can be toxic to the liver. Reporting at the 2015 Liver Meeting (AASLD) in San Francisco, CA, Vivek Chowdhary of Ohio State University Medical Center said he and colleagues are closing in on the mechanism involved in this type of hepatic cell death in hopes of finding a way to prevent this damage. Of liver failures caused by drugs, 41% of those cases involve acetaminophen poisoning, he said.

"It is also a major method of suicide," Chowdhary said.

Reporting on mouse studies in which he subjected the animals to acetaminophen overdoses,Chowdhary said the studies showed that microRNA 122 is a marker for liver injury. "It is reduced in acetaminophen poisoning," he said.

The main finding was that microRNA 122 suppresses hemoprotein genes cytochrome 2e1 and cytochrome 1a2.

Earlier studies have found that mice lacking cytochrome 2e1 are less sensitive to the hepatotoxic effects of acetaminophen.

The finding that microRNA 122 suppresses these cytochromes could lead the way to a therapy for acetaminophen poisoning, including a gene therapy. "This is the mechanism of liver necrosis in Tylenol overdoses," he said.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
Country-Level Socioeconomic Status, Healthcare Impact AKI Outcomes in Cirrhosis
© 2024 MJH Life Sciences

All rights reserved.